QQQ   423.41 (-0.57%)
AAPL   167.04 (-0.57%)
MSFT   404.27 (-1.84%)
META   501.80 (+1.54%)
GOOGL   156.01 (+0.35%)
AMZN   179.22 (-1.14%)
TSLA   149.93 (-3.55%)
NVDA   846.71 (+0.76%)
AMD   155.08 (+0.69%)
NIO   4.00 (+2.30%)
BABA   68.88 (+0.09%)
T   16.33 (+1.30%)
F   12.06 (+0.17%)
MU   111.93 (-3.78%)
GE   152.94 (-1.75%)
CGC   7.83 (+20.65%)
DIS   112.43 (-0.45%)
AMC   2.92 (-2.01%)
PFE   25.39 (-0.12%)
PYPL   62.10 (-1.83%)
XOM   118.52 (-0.09%)
QQQ   423.41 (-0.57%)
AAPL   167.04 (-0.57%)
MSFT   404.27 (-1.84%)
META   501.80 (+1.54%)
GOOGL   156.01 (+0.35%)
AMZN   179.22 (-1.14%)
TSLA   149.93 (-3.55%)
NVDA   846.71 (+0.76%)
AMD   155.08 (+0.69%)
NIO   4.00 (+2.30%)
BABA   68.88 (+0.09%)
T   16.33 (+1.30%)
F   12.06 (+0.17%)
MU   111.93 (-3.78%)
GE   152.94 (-1.75%)
CGC   7.83 (+20.65%)
DIS   112.43 (-0.45%)
AMC   2.92 (-2.01%)
PFE   25.39 (-0.12%)
PYPL   62.10 (-1.83%)
XOM   118.52 (-0.09%)
QQQ   423.41 (-0.57%)
AAPL   167.04 (-0.57%)
MSFT   404.27 (-1.84%)
META   501.80 (+1.54%)
GOOGL   156.01 (+0.35%)
AMZN   179.22 (-1.14%)
TSLA   149.93 (-3.55%)
NVDA   846.71 (+0.76%)
AMD   155.08 (+0.69%)
NIO   4.00 (+2.30%)
BABA   68.88 (+0.09%)
T   16.33 (+1.30%)
F   12.06 (+0.17%)
MU   111.93 (-3.78%)
GE   152.94 (-1.75%)
CGC   7.83 (+20.65%)
DIS   112.43 (-0.45%)
AMC   2.92 (-2.01%)
PFE   25.39 (-0.12%)
PYPL   62.10 (-1.83%)
XOM   118.52 (-0.09%)
QQQ   423.41 (-0.57%)
AAPL   167.04 (-0.57%)
MSFT   404.27 (-1.84%)
META   501.80 (+1.54%)
GOOGL   156.01 (+0.35%)
AMZN   179.22 (-1.14%)
TSLA   149.93 (-3.55%)
NVDA   846.71 (+0.76%)
AMD   155.08 (+0.69%)
NIO   4.00 (+2.30%)
BABA   68.88 (+0.09%)
T   16.33 (+1.30%)
F   12.06 (+0.17%)
MU   111.93 (-3.78%)
GE   152.94 (-1.75%)
CGC   7.83 (+20.65%)
DIS   112.43 (-0.45%)
AMC   2.92 (-2.01%)
PFE   25.39 (-0.12%)
PYPL   62.10 (-1.83%)
XOM   118.52 (-0.09%)
NASDAQ:UTRS

Minerva Surgical (UTRS) Stock Price, News & Analysis

$0.46
-0.05 (-9.80%)
(As of 01:44 PM ET)
Today's Range
$0.45
$0.55
50-Day Range
$0.51
$0.72
52-Week Range
$0.30
$14.00
Volume
7,330 shs
Average Volume
3,810 shs
Market Capitalization
$4.08 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$20.00
UTRS stock logo

About Minerva Surgical Stock (NASDAQ:UTRS)

Minerva Surgical, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes minimally invasive solutions to meet the uterine healthcare needs of women in the United States. The company provides Minerva ES Endometrial Ablation System and Genesys HTA Endometrial Ablation System, which are endometrial ablation devices; Symphion Tissue Removal System, a minimally invasive uterine tissue removal system to combine bladeless tissue resection and coagulation, continuous visualization, and intrauterine pressure monitoring; and Resectr Tissue Resection Device, a handheld surgical instrument to enable the hysteroscopic removal and diagnosis of endometrial polyps. Its devices are utilized by obstetrician-gynecologists in various medical treatment settings, including hospitals, ambulatory surgical centers, and physician offices. The company was incorporated in 2008 and is headquartered in Santa Clara, California.

UTRS Stock Price History

UTRS Stock News Headlines

Minerva Surgical (NASDAQ:UTRS) Trading Down 8.9%
The Next Nvidia?
The Next Nvidia? Wall Street legend has just uncovered one tiny Maryland company that could become the next Nvidia. Few in the media are talking about this story yet… but in the next 6 months that’s all they’ll talk about.
Minerva Surgical Inc.
Why Is Minerva Surgical (UTRS) Stock Down 50% Today?
Minerva Surgical Inc UTRS
The Next Nvidia?
The Next Nvidia? Wall Street legend has just uncovered one tiny Maryland company that could become the next Nvidia. Few in the media are talking about this story yet… but in the next 6 months that’s all they’ll talk about.
Patent Grant Sends Healthcare Shares Soaring Premarket
Q1 2023 Minerva Surgical Inc Earnings Call
Piper Sandler Remains a Buy on Minerva Surgical (UTRS)
Q4 2022 Minerva Surgical Inc Earnings Call
See More Headlines
Receive UTRS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Minerva Surgical and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
12/01/2021
Today
4/18/2024
Next Earnings (Estimated)
4/30/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
N/A
Current Symbol
NASDAQ:UTRS
Fax
N/A
Employees
174
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$20.00
High Stock Price Target
$20.00
Low Stock Price Target
$20.00
Potential Upside/Downside
+4,247.8%
Consensus Rating
Rating Score (0-4)
0.00
Research Coverage
0 Analysts

Profitability

Net Income
$-34,110,000.00
Pretax Margin
-64.61%

Debt

Sales & Book Value

Annual Sales
$50.29 million
Book Value
$11.52 per share

Miscellaneous

Free Float
8,124,000
Market Cap
$4.08 million
Optionable
Not Optionable
Beta
0.67
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.

Get This Free Report

Key Executives

  • Mr. Joel R. Jung MBA (Age 66)
    Chief Financial Officer
    Comp: $400.6k
  • Mr. Dominique J. Filloux (Age 61)
    Chief Operating Officer
    Comp: $390k
  • Mr. Todd Usen (Age 57)
    President, CEO & Director
  • Ms. Wendy Bowman
    Vice President of Human Resources
  • Dr. Evgueni V. Skalnyi M.D. (Age 58)
    Chief Medical Officer
    Comp: $365.25k
  • Ms. Kaile Zagger
    Chief Commercial Officer
  • Ms. Joanne Long
    Vice President of Corporate Controller

UTRS Stock Analysis - Frequently Asked Questions

What is Minerva Surgical's stock price target for 2024?

0 Wall Street analysts have issued 1 year price objectives for Minerva Surgical's shares. Their UTRS share price targets range from $20.00 to $20.00. On average, they expect the company's stock price to reach $20.00 in the next twelve months. This suggests a possible upside of 4,247.8% from the stock's current price.
View analysts price targets for UTRS
or view top-rated stocks among Wall Street analysts.

How have UTRS shares performed in 2024?

Minerva Surgical's stock was trading at $1.17 at the start of the year. Since then, UTRS shares have decreased by 60.7% and is now trading at $0.46.
View the best growth stocks for 2024 here
.

When is Minerva Surgical's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, April 30th 2024.
View our UTRS earnings forecast
.

How were Minerva Surgical's earnings last quarter?

Minerva Surgical, Inc. (NASDAQ:UTRS) issued its quarterly earnings results on Wednesday, December, 1st. The company reported ($23.00) earnings per share for the quarter, missing analysts' consensus estimates of ($8.80) by $14.20. The business had revenue of $12.51 million for the quarter, compared to analyst estimates of $12.23 million. Minerva Surgical had a negative net margin of 64.71% and a negative trailing twelve-month return on equity of 136.40%.

When did Minerva Surgical's stock split?

Minerva Surgical shares reverse split on Monday, October 2nd 2023. The 1-20 reverse split was announced on Monday, October 2nd 2023. The number of shares owned by shareholders was adjusted after the market closes on Monday, October 2nd 2023. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

When did Minerva Surgical IPO?

Minerva Surgical (UTRS) raised $100 million in an initial public offering (IPO) on Friday, October 22nd 2021. The company issued 6,250,000 shares at $15.00-$17.00 per share.

How do I buy shares of Minerva Surgical?

Shares of UTRS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:UTRS) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners